BiomX Inc.
Datakwaliteit: 83%
PHGE
NYSE
Manufacturing
Chemicals
€ 2,99
▲
€ 0,09
(3,10%)
Marktkapitalisatie: 19,57 M
Prijs
€ 2,99
Marktkapitalisatie
19,57 M
Dagbereik
€ 2,50 — € 3,00
52-Weeksbereik
€ 1,50 — € 14,71
Volume
119.428
Openen € 2,85
50D / 200D Gem.
€ 5,25
43,10% below
50D / 200D Gem.
€ 6,95
56,98% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -26,39 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-244,21%
Onder sectorgemiddelde (-53,41%)
ROIC-124,25%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio1,70
Interest Coverage-48,78
Waardering
PE (TTM)
-0,54
Boven sectorgemiddelde (-1,48)
P/B Ratio1,87
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,5 | -1,5 |
| P/B | 1,9 | 1,6 |
| ROE % | -244,2 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -36,20 M |
| ROE | -244,21% | ROA | -112,74% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -26,39 M |
| ROIC | -124,25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,70 |
| Interest Coverage | -48,78 | Asset Turnover | N/A |
| Working Capital | 3,64 M | Tangible Book Value | 10,49 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,54 | Forward P/E | N/A |
| P/B Ratio | 1,87 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -134,89% | ||
| Market Cap | 19,57 M | Enterprise Value | 12,64 M |
| Per Share | |||
| EPS (Diluted TTM) | 22,19 | Revenue / Share | N/A |
| FCF / Share | -4,03 | OCF / Share | -4,03 |
| EPS CAGR (1Y) | 560,42% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 72,91% |
| SBC-Adj. FCF | -29,01 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -36,20 M | -17,73 M | -26,17 M | -28,32 M | -36,23 M |
| EPS (Diluted) | 22,19 | 3,36 | 0,51 | 0,95 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -41,47 M | -44,52 M | -25,35 M | -27,22 M | -35,46 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 21,29 M | 24,66 M | 16,70 M | 16,24 M | 22,68 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | 871.000,0 | 2,52 M | 986.000,0 |
| Interest Expense | 850.000,0 | 850.000,0 | 2,40 M | 2,07 M | 983.000,0 |
| Income Tax | 7.000,0 | 13.000,0 | 23.000,0 | 65.000,0 | 67.000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,78 M | 43,23 M | 25,03 M | 45,53 M | 77,99 M |
| Total Liabilities | — | — | — | — | — |
| Shareholders' Equity | -1,30 M | 24,15 M | 3,08 M | 21,04 M | 47,54 M |
| Total Debt | — | 5,40 M | 11,19 M | 15,00 M | 15,00 M |
| Cash & Equivalents | 4,36 M | 16,86 M | 14,91 M | 31,33 M | 62,10 M |
| Current Assets | 5,58 M | 20,52 M | 17,63 M | 36,88 M | 66,64 M |
| Current Liabilities | 6,38 M | 8,27 M | 11,18 M | 7,94 M | 11,04 M |
{"event":"ticker_viewed","properties":{"ticker":"PHGE","listing_kind":"stock","pathname":"/stocks/phge","exchange":"NYSE","country":"US"}}